Browsing by Author Andrews RM

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 16 of 16
Publication DateTitleAuthor(s)TypeSubject
24-May-202010-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial.Oguoma VM; Wilson N; Mulholland K; Santosham M; Torzillo P; McIntyre P; Smith-Vaughan H; Balloch A; Chatfield M; Lehmann D; Binks MJ; Chang A; Carapetis JR; Krause VL; Andrews RM; Snelling T; Licciardi P; Morris PS; Leach AJJournal Article- 
Jun-2020Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006-15): a population-based cohort study.Binks MJ; Beissbarth J; Oguoma VM; Pizzutto SJ; Leach AJ; Smith-Vaughan HC; McHugh L; Andrews RM; Webby R; Morris PS; Chang ABJournal Article- 
2020Antibiotic use for Australian Aboriginal children in three remote Northern Territory communities.Howarth T; Brunette R; Davies T; Andrews RM; Patel BK; Tong SYC; Barzi F; Kearns TMJournal Article- 
Feb-2020Birth outcomes in Aboriginal mother-infant pairs from the Northern Territory, Australia, who received 23-valent polysaccharide pneumococcal vaccination during pregnancy, 2006-2011: The PneuMum randomised controlled trial.McHugh L; Binks M; Ware RS; Snelling T; Nelson S; Nelson J; Dunbar M; Mulholland EK; Andrews RMJournal ArticleAboriginal; pneumococcal; pregnancy; safety; vaccination 
2018Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia.Gidding HF; McCallum L; Fathima P; Moore HC; Snelling TL; Blyth CC; Jayasinghe S; Giele C; de Klerk N; Andrews RM; McIntyre PBJournal ArticleData linkage; Invasive pneumococcal disease; Pneumococcal conjugate vaccine; Vaccine effectiveness 
2015The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma.Bowen AC; Mahé A; Hay RJ; Andrews RM; Steer AC; Tong SYC; Carapetis JRJournal Article; Meta-Analysis; Review- 
25-Dec-2018Impact of the 23-valent pneumococcal polysaccharide vaccination in pregnancy against infant acute lower respiratory infections in the Northern Territory of Australia.Binks MJ; Moberley SA; Balloch A; Leach AJ; Nelson S; Hare KM; Wilson C; Nelson J; Morris PS; Ware RS; Tang MLK; Torzillo PJ; Carapetis JR; Mulholland K; Andrews RMJournal Article23-valent pneumococcal polysaccharide vaccine; Acute lower respiratory infection; Australia; Indigenous; Pregnancy 
20-Jun-2019'Links2HealthierBubs' cohort study: protocol for a record linkage study on the safety, uptake and effectiveness of influenza and pertussis vaccines among pregnant Australian women.Sarna M; Andrews RM; Moore H; Binks MJ; McHugh L; Pereira GF; Blyth CC; Van Buynder P; Lust K; Effler P; Lambert SB; Omer SB; Mak DB; Snelling T; D'Antoine HA; McIntyre P; de Klerk N; Foo D; Regan AKJournal Articleantenatal; immunisation; vaccine 
2020Maternal Anaemia in Pregnancy: A Significantly Greater Risk Factor for Anaemia in Australian Aboriginal Children than Low Birth Weight or Prematurity.Hansen M; Singh G; Barzi F; Brunette R; Howarth T; Morris PS; Andrews RM; Kearns TJournal Article- 
2018The NICE-GUT trial protocol: a randomised, placebo controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian Aboriginal children.Waddington CS; McLeod C; Morris PS; Bowen AC; Naunton M; Carapetis J; Grimwood K; Robins-Browne R; Kirkwood CD; Baird RW; Green D; Andrews RM; Fearon D; Francis JR; Marsh JA; Snelling TJournal ArticleBayesian inference; cryptosporidium; diarrhoea; gastrointestinal infections; nitazoxanide 
16-Jan-2015Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trial.Leach AJ; Mulholland EK; Santosham M; Torzillo PJ; Brown NJ; McIntyre P; Smith-Vaughan H; Skull S; Balloch A; Andrews RM; Carapetis J; McDonnell J; Krause VL; Morris PSComparative Study; Journal Article; Randomized Controlled TrialIMMUNOLOGY; MICROBIOLOGY; PUBLIC HEALTH 
2017Policy making for vaccine use as a driver of vaccine innovation and development in the developed world.Seib K; Pollard AJ; de Wals P; Andrews RM; Zhou F; Hatchett RJ; Pickering LK; Orenstein WAJournal Article; ReviewAustralia; Canada; Innovation; United Kingdom; United States; Vaccine development 
19-Oct-2015Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine.Leach AJ; Wigger C; Hare K; Hampton V; Beissbarth J; Andrews RM; Chatfield M; Smith-Vaughan H; Morris PSJournal Article- 
2014Standardising and assessing digital images for use in clinical trials: a practical, reproducible method that blinds the assessor to treatment allocation.Bowen AC; Burns K; Tong SYC; Andrews RM; Liddle R; O'Meara IM; Westphal DW; Carapetis JREvaluation Study; Journal Article- 
5-May-2020Strongyloides stercoralis seropositivity is not associated with increased symptoms in a remote Aboriginal community.Hansen M; Bowden E; Currie BJ; Ward L; Andrews RM; Dhurrkay RG; Gurruwiwi GG; Kearns TJournal ArticleEpidemiology; Mass Drug Administration; Neglected Diseases; Rural Health; Strongyloides 
24-Dec-2018Treatment, prevention and public health management of impetigo, scabies, crusted scabies and fungal skin infections in endemic populations: a systematic review.May PJ; Tong SYC; Steer AC; Currie BJ; Andrews RM; Carapetis JR; Bowen ACJournal Article; Reviewcrusted scabies; impetigo; scabies; tinea 
Showing results 1 to 16 of 16